Stryker Corporation
Stryker Corporation Completes $3.0 Billion Debt Offering
Summary
On February 10, 2025, Stryker Corporation completed a public offering of $3.0 billion aggregate principal amount of various notes due between 2027 and 2035. The offering was made pursuant to the company's Automatic Shelf Registration Statement on Form S-3 and the Prospectus included therein. The company expects to receive net proceeds of approximately $2.973 billion, after deducting underwriting discounts and estimated expenses. The notes were issued under an Indenture dated January 15, 2010, as supplemented by several supplemental indentures. The company intends to use the net proceeds to fund the acquisition of Inari Medical, Inc. and for general corporate purposes.
Profitelligence Alerts
Get alerts for SYK
Be first to know when Stryker Corporation files with the SEC.
Filing Categories
Exhibits (7)
Advertisement
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Official SEC Documents
Advertisement